Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients

Ms Fleur Peters
f.s.peters@amsterdamumc.nl

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000002759	ATACseq data of CD4+ and CD8+ T cells from patients with chronic lymphocytic leukemia (CLL) and age-matched healthy donors (HD) either at baseline or after 2 days of T cell stimulation with aCD3-CD28 soluable antibodies.	Illumina NovaSeq 6000	27